Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID 19 outpatients meta-analysis

Clemency, 2021
 
NCT04377711
RCTciclesonideplaceboCOVID 19 outpatientslow
197/203 inconclusive
    Ezer N (CONTAIN), 2021
     
    NCT04435795
    RCTciclesonideplaceboCOVID 19 outpatientssome concern
    108/107 inconclusive
    • inconclusive 25 % increase in recovery (PE) with a moderate degree of certainty due to some concern in risk of bias

    PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
    Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).